Furthermore, Kaplan-Meier analysis demonstrated 3-year lymphedema-free survival of 95% (90%-100%) versus 85% (77%-94%) for below versus above median concentrations of IFNα2A (P = 0.026). The gene discussed is IFNA2; the disease is lymphedema.